Provided by Tiger Fintech (Singapore) Pte. Ltd.

Surmodics

42.83
+1.222.93%
Post-market: 42.830.00000.00%19:58 EST
Volume:9.06M
Turnover:388.01M
Market Cap:612.37M
PE:-34.54
High:42.89
Open:42.82
Low:42.80
Close:41.61
52wk High:42.89
52wk Low:25.87
Shares:14.30M
Float Shares:12.27M
Volume Ratio:9.67
T/O Rate:73.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2402
EPS(LYR):-0.8155
ROE:-15.36%
ROA:-0.52%
PB:5.50
PE(LYR):-52.52

Loading ...

U.S. Court Denies U.S. Federal Trade Commission's Bid to Block Gtcr's Acquisition of Surmodics – Court Hearing

THOMSON REUTERS
·
Nov 11

Surmodics Shares Halted for News Pending; Last up 2.1% at $27.34

THOMSON REUTERS
·
Nov 11

SurModics trading halted, news pending

TIPRANKS
·
Nov 11

BRIEF-Surmodics Shares Data From 160 Patients In PROWL Registry Using Pounce For Real-World Limb Ischemia

Reuters
·
Nov 04

Surmodics Reports High Success Rates for Pounce Thrombectomy Device in Real-World Limb Ischemia Study

Reuters
·
Nov 04

Surmodics Inc - Device Technical Success 83.2% With <50% Residual Obstruction

THOMSON REUTERS
·
Nov 04

Surmodics Inc - Procedural Success 91.7%, Device-Related Adverse Events 0.6%

THOMSON REUTERS
·
Nov 04

Surmodics Inc - 94.8% Patients Experienced Post-Procedural Blood Flow Restoration

THOMSON REUTERS
·
Nov 04

Surmodics Announces Outcomes From 160 Patients in Prowl Registry Evaluating Pounce™ Thrombectomy Platform in Treatment of Real-World Limb Ischemia Presentations

THOMSON REUTERS
·
Nov 04

SurModics Unveils Positive PROWL Registry Data on Pounce Thrombectomy Platform at VIVA Conference

Reuters
·
Nov 03

Surmodics announces results from PROWL registry study

TIPRANKS
·
Oct 30

SurModics Unveils Sex-Specific Results for Pounce Thrombectomy Device in PROWL Registry Study

Reuters
·
Oct 28

Surmodics Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 08

Surmodics Q3 EPS USD -0.37

Reuters
·
Aug 08

Surmodics Q3 Adj. EPS $0.06 Beats $(0.19) Estimate, Sales $29.567M Beat $28.055M Estimate

Benzinga
·
Aug 08

SurModics Inc. Reports Q3 FY 2025 Revenue Decrease of 3%, GAAP Loss Narrows to $5.3 Million; Adjusted EBITDA Rises to $3.4 Million

Reuters
·
Aug 08

Surmodics Q3 Pretax Profit USD -5.929 Million

THOMSON REUTERS
·
Aug 08

Surmodics Inc Outlook FY Adj Loss per Share $0.35 to $0.20

THOMSON REUTERS
·
Aug 08

SurModics Reports Cyberattack, Says Critical IT Systems Restored

MT Newswires Live
·
Jul 03

BRIEF-Surmodics Reports Unauthorized Access To It Systems

Reuters
·
Jul 02